期刊文献+

乙肝病毒核心蛋白真核表达载体的构建与表达 被引量:1

Construction of eukaryotic expression vectors containing the HBc gene and their expressions in the human hepatoma cell line
原文传递
导出
摘要 目的构建2种包含乙肝病毒核心蛋白(HBc)基因的真核表达载体,检测其在人肝癌细胞系BEL7402中的表达。方法以质粒pUC19/3.0HBV作为模板,PCR扩增HBc基因,分别以pcDNA3.0和pEGFP-N1为母本,构建含HBc基因的真核表达载体pcDNA-HBc-HA及pEGFP-HBc。通过单、双酶切、PCR及DNA测序鉴定其正确性。利用脂质体将其分别转染入人肝癌细胞系BEL7402,并采用RT-PCR、Western blot及荧光显微镜观察的方法,分别检测其mRNA、蛋白质水平的表达。结果获得与预期分子量大小一致的DNA片段,转染2种质粒的BEL7402细胞均可高水平表达HBc mRNA,而空载体转染组则无表达,转染pEGFP-HBc转染组及pEGFP-N1转染组,均有较强的绿色荧光表达,pcDNA-HBc-HA转染组细胞可检测到HBc-HA融合蛋白的表达。结论成功构建2种携载HBc基因的真核表达载体,并可在人肝癌细胞系BEL7402中有效表达。 Objective To construct two eukaryotic expression vectors containing the HBc gene and to observe their expressions in the human hepatoma cell line. Methods We used pUC19/3.0HBV as a template to amplify the HBc gene with the PCR method, pcDNA3.0 and pEGFP-N1 were introduced to construct the expression vectors of pcDNA-HBc-HA and pEGFP-HBc, respectively. PCR, restriction endonuclease digestion and DNA sequencing were used to select the positive plasmids. Then, BELT402 cells were separately transfected with pcDNA-HBc-HA, pEGFP-HBc and their empty control vectors by liposome. The HBc mRNA and protein levels were further determined by RT-PCR, Western blot and a fluorescent microscope. Results The recombinant plasmids containing HBc gene were successfully constructed. Single and double enzyme digestion showed that both the recombinant plasmids contained the inserted gene fragments with the anticipated molecular weight. RT-PCR showed that high level of HBc mRNA was detected in BELT402 cells transfected with pcDNA-HBc-HA and pEGFP-HBc expression vectors, while there was no HBc gene expression in control cells transfected with pcDNA3.0 or pEGFP-N1. The green fluorescence protein was expressed in the pEGFP- HBc group and the pEGFP-N1 group, and HBc-HA protein was detected in the pcDNA-HBc-HA group by Western blot. Conclusion Two eukaryotic expression vectors with the HBc gene were successfully constructed and both of them were effectively expressed in BELT402 cells.
出处 《山东大学学报(医学版)》 CAS 北大核心 2010年第2期67-71,共5页 Journal of Shandong University:Health Sciences
基金 国家自然科学基金资助课题(30700973)
关键词 肝炎 乙型 病毒核心蛋白质类 遗传载体 基因表达 Hepatitis B Viral core proteins Genetic vectors Gene expression
  • 相关文献

参考文献13

  • 1李连弟,鲁凤珠,张思维,牧人,孙秀娣,皇甫小梅,孙杰,周有尚,欧阳宁慧,饶克勤,陈育德,孙爱明,薛志福,夏毅.中国恶性肿瘤死亡率20年变化趋势和近期预测分析[J].中华肿瘤杂志,1997,19(1):3-9. 被引量:869
  • 2Leon D A, McCambridge J. Liver cirrhosis mortality rates in Britain from 1950 to 2002: an analysis of routine data [J]. Lancet, 2006, 367(9504):52-56.
  • 3Liu D X. A new hypothesis of pathogenetic mechanism of viral hepatitis B and C [ J]. Medical Hypotheses, 2001,56 ( 3 ) :405-408.
  • 4Di Marco V, Lo Iacono O, Camma C, et al. The long-term course of chronic hepatitis B [J].Hepatology, 1999, 30 ( 1 ) :257-264.
  • 5骆抗先.乙型肝炎:基础与临床[M].第2版.北京:人民卫生出版社,2003:25-74.
  • 6Du J, Liang X, Liu Y, et al. Hepatitis B virus core protein inhibits TRAIL-inoduced apoptosis of hepatocytes by blocking DR5 expression [J].Cell Death Differ, 2009, 16 (2) :219-229.
  • 7Lavanchy D. Hepatitis B virus epidemiology,disease burden, treatment, and current and emerging prevention and control measures[J]. J Viral Hepat, 2004, 11 ( 2 ) : 97- 107.
  • 8Donlinguez-Malagon H, Gaytan-Graham S. Hepatocellular carcinoma: an update[J]. Ultrastruct pathol, 2001, 25 (6) :497-516.
  • 9Marotta F, Vangieri B, Cecere A, et al. The pathogenesis of hepatocellular carcinoma is multifactorial event Novel immunological treatment in prospect [ J ]. Clin Ter, 2004, 155(5) :187-199.
  • 10Milich DRA. McLachlan. The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen[ J]. Science, 1986, 234(4782) : 1398-1401.

共引文献868

同被引文献13

  • 1Shepard C W, Simard E P, Finelli L, et al. Hepatitis B virus infection : epidemiology and vaccination. Epidemiol Rev, 2006, 28 : 112-125.
  • 2Liaw Y F, Kao J H, Teerha P, et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update. Hepatol lnt, 2012, 72 ( 12 ) :9365-9369.
  • 3Seeger C, Mason W. Hepatitis B virus biology. Microbiol Mol Biol, 2000, 64:51-68.
  • 4Katrin B, Robert T. Natural history of chronic hepatitis B vires infection. Med Microbiol Immunol, 2014, 14:369-376.
  • 5Kenny R, Sarah D B, Bert S, et al. Hepatitis B core-based virus- like particles to present heterologous epitopes. Vaccines, 2013, 12(2) :183-198.
  • 6Smith G E, Fraser M J, Summers M D. Molecular engineering of the Autographa califarnica nuclear polyhedrosis virus genome:deletion mutations within the polyhedron gene. Journal of Virology, 1983, 46(2) :584-593.
  • 7Emma J C, Henry C K. CervarixTM- a bivalent L1 virus-like particle vaccine for prevention of human papillomavirus type 16- and 18-associated cervical cancer. Biol. Ther, 2007,7(3) :391- 396.
  • 8Kate T. First recombinant flu vaccine approved. Am J Health-Syst Pharm, 2013, 70:382.
  • 9Capon D J, Chamow S W, Mordenti J, et al. Designing CD4 immunoadhesins for AIDS therapy. Nature, 1989, 337 ( 6207 ) : 525-531.
  • 10朱小静,姜潮,薛萍,王晓艳,徐丹,南佳,艾君,李校堃.重组角质细胞生长因子-1在杆状病毒表达系统中的表达及其生物活性研究[J].中国生物工程杂志,2013,33(3):47-53. 被引量:3

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部